Cargando…
DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
Autores principales: | Hilton, Traci L, Hulett, Tyler W, Dubay, Chistopher, van de Ven, Rieneke, Aung, Sandra, Urba, Walter J, Hu, Hong Ming, Fox, Bernard A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991108/ http://dx.doi.org/10.1186/2051-1426-1-S1-P260 |
Ejemplares similares
-
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
por: van de Ven, Rieneke, et al.
Publicado: (2018) -
Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs
por: Yi, Yongxiang, et al.
Publicado: (2012) -
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
por: Hilton, Traci, et al.
Publicado: (2014) -
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015) -
Novel strategy to monitor apparent tumor-specific T cells in patients with cancer
por: van de Ven, Rieneke, et al.
Publicado: (2013)